A Study to Assess AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)
Public ClinicalTrials.gov record NCT04322604. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of AK002 in Patients With Moderately to Severely Active Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 3, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of lirentelimab (AK002), given monthly for 6 doses, in patients with moderately to severely active Eosinophilic Gastritis and/or Eosinophilic Duodenitis (formerly referred to as Eosinophilic Gastroenteritis) who have an inadequate response with, lost response to, or were intolerant to standard therapies
Study identification
- NCT ID
- NCT04322604
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 181 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 18, 2020 (Actual)
- Primary completion
- Nov 29, 2021 (Actual)
- Completion
- Jan 12, 2022 (Actual)
- Last update posted
- Jan 2, 2024
2020 – 2022
United States locations
- U.S. sites
- 60
- U.S. states
- 26
- U.S. cities
- 57
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Allakos Investigational Site | Birmingham | Alabama | 35209 | — |
| Allakos Investigational Site | Huntsville | Alabama | 38801 | — |
| Allakos Investigational Site | Gilbert | Arizona | 85234 | — |
| Allakos Investigational Site | Phoenix | Arizona | 85021 | — |
| Allakos Investigational Site | Scottsdale | Arizona | 85259 | — |
| Allakos Investigational Site | Little Rock | Arkansas | 72205 | — |
| Allakos Investigational Site | Chula Vista | California | 91910 | — |
| Allakos Investigational Site | La Jolla | California | 92037 | — |
| Allakos Investigational Site | Murrieta | California | 92563 | — |
| Allakos Investigational Site | Oakland | California | 94612 | — |
| Allakos Investigational Site | Santa Monica | California | 90404 | — |
| Allakos Investigational Site | Tustin | California | 92780 | — |
| Allakos Investigational Site | Ventura | California | 93003 | — |
| Allakos Investigational Site | Walnut Creek | California | 94598 | — |
| Allakos Investigational Site | Aurora | Colorado | 80045 | — |
| Allakos Investigational Site | Colorado Springs | Colorado | 80907 | — |
| Allakos Investigational Site | Bristol | Connecticut | 06010 | — |
| Allakos Investigational Site | Brandon | Florida | 33511 | — |
| Allakos Investigational Site | Edgewater | Florida | 32132 | — |
| Allakos Investigational Site | Jacksonville | Florida | 32256 | — |
| Allakos Investigational Site | Miami | Florida | 33176 | — |
| Allakos Investigational Site | New Port Richey | Florida | 34653 | — |
| Allakos Investigational Site | Atlanta | Georgia | 30342 | — |
| Allakos Investigational Site | Chicago | Illinois | 60611 | — |
| Allakos Investigational Site | Crowley | Louisiana | 70526 | — |
| Allakos Investigational Site | Chevy Chase | Maryland | 20815 | — |
| Allakos Investigational Site | Boston | Massachusetts | 02111 | — |
| Allakos Investigational Site | Boston | Massachusetts | 02115 | — |
| Allakos Investigational Site | Boston | Massachusetts | 02215 | — |
| Allakos Investigational Site | Ann Arbor | Michigan | 48109 | — |
| Allakos Investigational Site | Rochester | Minnesota | 55905 | — |
| Allakos Investigational Site | Kansas City | Missouri | 64108 | — |
| Allakos Investigational Site | Las Vegas | Nevada | 89106 | — |
| Allakos Investigational Site | Reno | Nevada | 89511 | — |
| Allakos Investigational Site | Great Neck | New York | 11021 | — |
| Allakos Investigational Site | New York | New York | 10029 | — |
| Allakos Investigational Site | Chapel Hill | North Carolina | 27599 | — |
| Allakos Investigational Site | Charlotte | North Carolina | 28210 | — |
| Allakos Investigational Site | Durham | North Carolina | 27710 | — |
| Allakos Investigational Site | Rocky Mount | North Carolina | 27804 | — |
| Allakos Investigational Site | Cincinnati | Ohio | 45229 | — |
| Allakos Investigational Site | Cincinnati | Ohio | 45231 | — |
| Allakos Investigational Site | Cleveland | Ohio | 44106 | — |
| Allakos Investigational Site | Dayton | Ohio | 45415 | — |
| Allakos Investigational Site | Mentor | Ohio | 44060 | — |
| Allakos Investigational Site | Oklahoma City | Oklahoma | 73112 | — |
| Allakos Investigational Site | Danville | Pennsylvania | 17822 | — |
| Allakos Investigational Site | Philadelphia | Pennsylvania | 19104 | — |
| Allakos Investigational Site | Chattanooga | Tennessee | 37421 | — |
| Allakos Investigational Site | Hixson | Tennessee | 37343 | — |
| Allakos Investigational Site | Kingsport | Tennessee | 37663 | — |
| Allakos Investigational Site | Nashville | Tennessee | 37212 | — |
| Allakos Investigational Site | Austin | Texas | 78704 | — |
| Allakos Investigational Site | Houston | Texas | 77070 | — |
| Allakos Investigational Site | Ogden | Utah | 84405 | — |
| Allakos Investigational Site | Riverton | Utah | 84065 | — |
| Allakos Investigational Site | Salt Lake City | Utah | 84132 | — |
| Allakos Investigational Site | Sandy City | Utah | 84092 | — |
| Allakos Investigational Site | Fairfax | Virginia | 22031 | — |
| Allakos Investigational Site | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04322604, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 2, 2024 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04322604 live on ClinicalTrials.gov.